Literature DB >> 28089154

Pre-hospital electrocardiogram triage with telemedicine near halves time to treatment in STEMI: A meta-analysis and meta-regression analysis of non-randomized studies.

Natale Daniele Brunetti1, Luisa De Gennaro2, Michele Correale3, Francesco Santoro4, Pasquale Caldarola2, Antonio Gaglione5, Matteo Di Biase5.   

Abstract

BACKGROUND: A shorter time to treatment has been shown to be associated with lower mortality rates in acute myocardial infarction (AMI). Several strategies have been adopted with the aim to reduce any delay in diagnosis of AMI: pre-hospital triage with telemedicine is one of such strategies. We therefore aimed to measure the real effect of pre-hospital triage with telemedicine in case of AMI in a meta-analysis study.
METHODS: We performed a meta-analysis of non-randomized studies with the aim to quantify the exact reduction of time to treatment achieved by pre-hospital triage with telemedicine. Data were pooled and compared by relative time reduction and 95% C.I.s. A meta-regression analysis was performed in order to find possible predictors of shorter time to treatment.
RESULTS: Eleven studies were selected and finally evaluated in the study. The overall relative reduction of time to treatment with pre-hospital triage and telemedicine was -38/-40% (p<0.001). Absolute time reduction was significantly correlated to time to treatment in the control groups (p<0.001), while relative time reduction was independent. A non-significant trend toward shorter relative time reductions was observed over years.
CONCLUSIONS: Pre-hospital triage with telemedicine is associated with a near halved time to treatment in AMI. The benefit is larger in terms of absolute time to treatment reduction in populations with larger delays to treatment. Copyright Â
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute myocardial infarction; Pre-hospital electrocardiogram; Telemedicine; Time-to-balloon; Triage

Mesh:

Year:  2017        PMID: 28089154     DOI: 10.1016/j.ijcard.2017.01.055

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  14 in total

1.  Paramedic versus physician-staffed ambulances and prehospital delays in the management of patients with ST-segment elevation myocardial infarction.

Authors:  Artur Borowicz; Klaudiusz Nadolny; Kamil Bujak; Daniel Cieśla; Mariusz Gąsior; Bartosz Hudzik
Journal:  Cardiol J       Date:  2019-07-17       Impact factor: 2.737

2.  Impact of a telemedicine-guided, population-based, STEMI network on reperfusion strategy, efficiency, and outcomes: Impact of telemedicine on STEMI management.

Authors:  Sameer Mehta; Haytham Aboushi; Carlos Campos; Roberto Botelho; Francisco Fernandez; Daniel Rodriguez; Mario Torres; Daniel Vieria; Alejandra Frauenfelder; Gladys Pinto; Claudia Lopez; Maria Acosta
Journal:  AsiaIntervention       Date:  2021-07

3.  Association of Financial Factors and Telemedicine Adoption for Heart Attack and Stroke Care Among Rural and Urban Hospitals: A Longitudinal Study.

Authors:  Amir Alishahi Tabriz; Kea Turner; Dunc Williams; Nimmy Babu; Steve North; Christopher M Shea
Journal:  Telemed J E Health       Date:  2021-09-24       Impact factor: 5.033

4.  The transtelephonic electrocardiogram-based triage is an independent predictor of decreased hospital mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Gyorgy Papai; Gabor Csato; Ildiko Racz; Gabor Szabo; Tamas Barany; Agnes Racz; Miklos Szokol; Balazs Sarman; Istvan F Edes; Daniel Czuriga; Rudolf Kolozsvari; Istvan Edes
Journal:  J Telemed Telecare       Date:  2018-12-10       Impact factor: 6.184

5.  Patient-tailored triage decisions by anaesthesiologist-staffed prehospital critical care teams: a retrospective descriptive study.

Authors:  Morten Langfeldt Friberg; Leif Rognås
Journal:  BMJ Open       Date:  2018-07-18       Impact factor: 2.692

6.  Prognostic Implications of Door-to-Balloon Time and Onset-to-Door Time on Mortality in Patients With ST -Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.

Authors:  Jonghanne Park; Ki Hong Choi; Joo Myung Lee; Hyun Kuk Kim; Doyeon Hwang; Tae-Min Rhee; Jihoon Kim; Taek Kyu Park; Jeong Hoon Yang; Young Bin Song; Jin-Ho Choi; Joo-Yong Hahn; Seung-Hyuk Choi; Bon-Kwon Koo; Shung Chull Chae; Myeong Chan Cho; Chong Jin Kim; Ju Han Kim; Myung Ho Jeong; Hyeon-Cheol Gwon; Hyo-Soo Kim
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

Review 7.  Confronting system barriers for ST- elevation MI in low and middle income countries with a focus on India.

Authors:  Sameer Mehta; Christopher Granger; Cindy Lee Grines; Alice Jacobs; Timothy D Henry; Ivan Rokos; Alexandra Lansky; Andreas Baumbach; Roberto Botelho; Alexandra Ferre; Isaac Yepes; Roopa Salwan; Jamshed Dalal; Jitendra Makkar; Neeraj Bhalla; Sundeep Mishra; Vinod Vijan; Shirish Hiremath
Journal:  Indian Heart J       Date:  2017-07-06

8.  Clinical Competence in ST-segment Elevation Myocardial Infarction Management by Recently Graduated Physicians Applying for a Medical Residency Program.

Authors:  Ugo Stocco Aimoli; Carlos Henrique Miranda
Journal:  Arq Bras Cardiol       Date:  2020-01       Impact factor: 2.000

9.  Assessment of diagnostic accuracy of SanketLife - A wireless, pocket-sized ECG biosensor, in comparison to standard 12 lead ECG in the detection of cardiovascular diseases in a tertiary care setting.

Authors:  Siva Kumar; C M Nagesh; Manmohan Singh; Anbu Pandian; David Delurgio; Bobby Khan; Robin Chaudhary; Prashant Gupta
Journal:  Indian Pacing Electrophysiol J       Date:  2019-12-20

10.  2019 Italian Society of Cardiology Census on telemedicine in cardiovascular disease: a report from the working group on telecardiology and informatics.

Authors:  Natale Daniele Brunetti; Giuseppe Molinari; Flavio Acquistapace; Tecla Zimotti; Gianfranco Parati; Ciro Indolfi; Francesco Fedele; Stefano Carugo
Journal:  Open Heart       Date:  2020-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.